文献速递心脑血管急症重症综合管理与镇静镇痛

无住院天数:心脏骤停患者中以患者为中心的临床相关结局指标

Number of hospital-free days: a clinically relevant patient-centered outcome in cardiac arrest patients.
PubMed 文献 · Resuscitation · 2025-12-22
一句话结论在253例心脏骤停患者中,第90天无住院天数与改良Rankin量表强相关,AUROC达0.92–0.96,可作为未来试验的结局指标。

该研究使用法国2个中心参与国家AfterRoSC网络的前瞻性收集数据,纳入253例心脏骤停患者,计算第90天无住院天数(HFD-d90),即存活且在家、排除索引住院的天数。第90天死亡率为55%,改良Rankin量表为6 [1-6],HFD-d90中位数为0 [0-68]天,均值为27天(标准差35)。HFD-d90与改良Rankin量表强相关,HFD-d90对比二值化改良Rankin量表的AUROC为0.92 [0.88; 0.96]至0.96 [0.93; 0.99]。作者认为HFD-d90是临床相关且可能有用的结局指标,可用于未来心脏骤停患者的试验。

要点

  • 在253例心脏骤停患者中,第90天死亡率为55%,改良Rankin量表为6 [1-6]。
  • HFD-d90中位数为0 [0-68]天,均值为27天(标准差35)。
  • HFD-d90与改良Rankin量表强相关,对比mRs 0 vs. 1-6的AUROC为0.92 [0.88; 0.96]。
  • 对比mRs 0-1 vs. 2-6、0-2 vs. 3-6、0-3 vs. 4-6的AUROC分别为0.95 [0.92; 0.98]、0.96 [0.93; 0.99]、0.96 [0.93; 0.98]。
  • 作者认为HFD-d90是临床相关且可能有用的结局指标,可用于未来心脏骤停患者的试验。

适用人群与场景

  • 法国2个中心参与国家AfterRoSC网络的前瞻性收集数据中的心脏骤停患者,共253例。

研究设计与关键结果

  • 研究类型为使用法国2个中心参与国家AfterRoSC网络的前瞻性收集数据的分析,纳入253例心脏骤停患者。
  • 第90天死亡率为55%,改良Rankin量表为6 [1-6]。
  • HFD-d90中位数为0 [0-68]天,均值为27天(标准差35)。
  • HFD-d90与改良Rankin量表强相关,对比mRs 0 vs. 1-6、0-1 vs. 2-6、0-2 vs. 3-6、0-3 vs. 4-6的AUROC分别为0.92 [0.88; 0.96]、0.95 [0.92; 0.98]、0.96 [0.93; 0.99]、0.96 [0.93; 0.98]。

证据类型、等级与局限

  • 证据类型为使用前瞻性收集数据的分析,原文未报告证据等级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为HFD-d90是临床相关且可能有用的结局指标,可用于未来心脏骤停患者的试验。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: Patient centered-outcome should be considered in cardiac arrest patients but might be sometimes difficult to collect. The number of hospital-free days (HFD) has been reported strongly associated with neurological outcome in stroke patients and mid-term survival and quality of life in critically ill patients. Very few data has been reported about cardiac arrest (CA) patients so far.

PATIENTS AND METHODS: We used prospectively collected data from 2 French centers involved in the national network AfterRoSC. HFD at day-90 (HFD-d90) was calculated as the number of days alive and at home, excluding the index hospitalization. Correlation of HFD-d90 with the modified Rankin scale (mRs) was calculated as well as areas under the receiver- operator-curves (AUROC) of HFD-d90 versus binarized mRs.

RESULTS: 253 patients were included with a day-90 mortality of 55 %. Modified Rankin scale was 6 [1-6]. Median HFD-d90 was 0 [0-68] days and mean HFD-d90 was 27 (sd 35) days. We observed a strong correlation between modified Rankin scale and HFD-d90. Area under the ROC was 0.92 [0.88; 0.96], 0.95 [0.92; 0.98], 0.96 [0.93; 0.99], 0.96 [0.93; 0.98] for the following comparisons mRs 0 vs. 1-6, 0-1 vs. 2-6, 0-2 vs. 3-6 and 0-3 vs. 4-6, respectively.

CONCLUSION: HFD-d90 is a clinically relevant and potentially useful outcome to be used in future trials in CA patients.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Geri G, Gouge AL, Lascarrou JB, et al. Number of hospital-free days: a clinically relevant patient-centered outcome in cardiac arrest patients. Resuscitation. 2025. PMID: 41443581. doi:10.1016/j.resuscitation.2025.110937

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。